Therapeutic options in the management of toxic and nontoxic nodular goiter
Tóm tắt
Từ khóa
Tài liệu tham khảo
Matovinovic, 1983, Endemic goiter and cretinism at the dawn of the third millennium, Ann Rev Nutr, 3, 341, 10.1146/annurev.nu.03.070183.002013
Marine, 1923, Prevention and treatment of simple goiter, Atlantic Med J, 26, 437
Matovinovic, 1978, David Marine (1880–1976): Nestor of thyroidology, Perspect Biol Med, 21, 565, 10.1353/pbm.1978.0035
Hollowell, 1998, Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971–1974 and 1988–1994), J Clin Endocrinol Metab, 83, 3401
Dunn, 1998, The prevention and management of iodine-induced hyperthyroidism and its cardiac features, Thyroid, 8, 101, 10.1089/thy.1998.8.101
Studer, 1992, Histomorphological and immunohistochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells, J Clin Endocrinol Metab, 75, 1151
Tonacchera, 1998, Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma, J Clin Endocrinol Metab, 83, 492
Berghout, 1990, Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter, Am J Med, 89, 602, 10.1016/0002-9343(90)90178-G
DeKlerk, 1997, Iodine-131 therapy in sporadic nontoxic goiter, J Nucl Med, 38, 372
Nygaard, 1996, Improvement of upper airway obstruction after I-131 treatment of multinodular nontoxic goiter evaluated by flow volume loop curves, J Endocrinol Invest, 19, 71, 10.1007/BF03349839
Berghout, 1990, Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre, Lancet, 336, 193, 10.1016/0140-6736(90)91730-X
Cooper, 1983, Agranulocytosis associated with antithyroid drugs: effects of patient age and drug dose, Ann Intern Med, 98, 26, 10.7326/0003-4819-98-1-26
Gorman, 1978, Radiation dose in the selection of I-131 or surgical treatment for toxic thyroid adenoma, Ann Intern Med, 89, 85, 10.7326/0003-4819-89-1-85
Kaplan, 1998, Treatment of hyperthyroidism with radioactive iodine, Endocrinol Metab Clin North Am, 27, 205, 10.1016/S0889-8529(05)70307-8
Ferrari, 1996, Treatment of the autonomous thyroid nodule. A review, Eur J Endocrinol, 135, 383, 10.1530/eje.0.1350383
Mack, 1995, Management of patients with substernal goiters, Surg Clin North Am, 75, 377, 10.1016/S0039-6109(16)46628-4
Erickson, 1998, Treatment of patients with toxic multinodular goiter, Thyroid, 8, 277, 10.1089/thy.1998.8.277
Hermus, 1998, Treatment of benign nodular thyroid disease, N Engl J Med, 338, 1438, 10.1056/NEJM199805143382007
Ross, 1984, Successful treatment of solitary toxic thyroid adenomas with relatively lowdose iodine-131, with low prevalence of hypothyroidism, Ann Intern Med, 101, 488, 10.7326/0003-4819-101-4-488
Ng Tang Fui, 1979, Standard dose I-131 therapy for hyperthyroidism caused by autonomously functioning thyroid nodules, Clin Endocrinol (Oxf), 10, 69, 10.1111/j.1365-2265.1979.tb03035.x
Hamburger, 1987, The autonomously functioning thyroid nodule: Goetsch's disease, Endocr Rev, 8, 439, 10.1210/edrv-8-4-439
Huysmans, 1991, Longterm follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine, J Nucl Med, 32, 27
Estour, 1997, Efficacy of low doses of radioiodine in the treatment of autonomous thyroid nodules: importance of dose/area ratio, Thyroid, 7, 357, 10.1089/thy.1997.7.357
Eyre-Brook, 1982, The treatment of autonomous functioning thyroid nodules, Br J Surg, 69, 577, 10.1002/bjs.1800691006
Mariotti, 1986, Serum thyroid autoantibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single thyroid “hot” nodule, Acta Endocrinol, 113, 500, 10.1530/acta.0.1130500
Nygaard, 1994, Long-term follow-up of thyroid scintigraphies after I-131 therapy of solitary autonomous thyroid nodules, Thyroid, 4, 167, 10.1089/thy.1994.4.167
Huysmans, 1993, Long-term results of two schedules of radioiodine treatment for toxic multinodular goitre, Eur J Nucl Med, 20, 1056, 10.1007/BF00173483
Hamburger, 1985, Diagnosis and management of large toxic multinodular goiters, J Nucl Med, 26, 888
Franklyn, 1995, Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism, QJM, 88, 175
US Nuclear Regulatory Commission, 1997, 1997 criteria for release of individuals administered radioactive materials, Federal Register, 62, 4120
Nygaard, 1996, I-131 treatment of nodular non-toxic goitre, Eur J Endocrinol, 134, 15, 10.1530/eje.0.1340015
Huysmans, 1994, Magnetic resonance imaging for volume estimation of large multinodular goiters: a comparison with scintigraphy, Br J Radiol, 67, 519, 10.1259/0007-1285-67-798-519
Nygaard, 1994, Acute changes in thyroid volume and function following I-131 therapy of multinodular goitre, Clin Endocrinol, 41, 715, 10.1111/j.1365-2265.1994.tb02784.x
Huysmans, 1994, Large compressive goiters treated with radioiodine, Ann Intern Med, 121, 757, 10.7326/0003-4819-121-10-199411150-00005
Huysmans, 1997, Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters, Thyroid, 7, 535, 10.1089/thy.1997.7.535
Huysmans, 1996, Dosimetry and risk estimates of radioiodine therapy for large multinodular goiters, J Nucl Med, 37, 2072
Livraghi, 1990, Treatment of autonomous functioning thyroid nodules with percutaneous ethanol injection: preliminary results, Radiology, 175, 827, 10.1148/radiology.175.3.2188302
Lippi, 1996, Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter trial, J Clin Endocrinol Metab, 81, 3261